Literature DB >> 12030608

Comparison of the criteria forgestational diabetes mellitus by NDDG and Carpenter and Coustan, and the outcomes of pregnancy.

A Gokcel1, T Bagis, E B Killicadag, E Tarim, N Guvener.   

Abstract

This is a retrospective study to compare the criteria for diagnosis of gestational diabetes mellitus (GDM) by the National Diabetes Data Group (NDDG), and Carpenter and Coustan criteria, and to study the outcome of GDM when diagnosed by the more sensitive criteria. Six hundred and sixty-two pregnant women were included in this study from the medical records between September 1998 and April 2001. GDM was positive in 6.50% of patients according to Carpenter and Coustan and in 4.08% of patients according to NDDG criteria. Women with GDM were older, had higher fasting and glucose challenge test (GCT) glucose levels, and fetal weight than the normal women. Hypoglycemia was observed only in one infant. Regarding pre-term delivery and pre-eclampsia, there was no significant difference between the groups. Age, delivery week and fetal weight of patients who had caesarian delivery were significantly higher than spontaneous vaginal delivery. Prevalence of macrosomia in GDM group was higher than in the normal group. There was a significant correlation between the macrosomia and number of positive blood glucose values during OGTT. In multivariate analyses, fasting, GCT and second hour OGTT blood glucose levels, mean parity, and delivery week were independent risk factors for fetal weight. Carpenter and Coustan criteria is more sensitive than the NDDG criteria and women with GDM had a higher frequency of macrosomia and the frequency of macrosomia increases by the number of positive blood glucose levels during OGTT. Tight glycemic control might decrease the prevalence of caesarian delivery, pre-eclampsia, pre-term delivery and hypoglycemia of the infant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030608     DOI: 10.1007/BF03344018

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Gestational impaired glucose tolerance does not increase perinatal mortality in a developing country: cohort study.

Authors:  S Ramtoola; P Home; H Damry; A Husnoo; S Ah-Kion
Journal:  BMJ       Date:  2001-04-28

2.  CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY.

Authors:  J B O'SULLIVAN; C M MAHAN
Journal:  Diabetes       Date:  1964 May-Jun       Impact factor: 9.461

Review 3.  Neonatal morbidities in gestational diabetes mellitus.

Authors:  B Persson; U Hanson
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

4.  Management and outcome of class A diabetes mellitus.

Authors:  S G Gabbe; J G Mestman; R K Freeman; G V Anderson; R I Lowensohn
Journal:  Am J Obstet Gynecol       Date:  1977-03-01       Impact factor: 8.661

Review 5.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

Authors:  S Meltzer; L Leiter; D Daneman; H C Gerstein; D Lau; S Ludwig; J F Yale; B Zinman; D Lillie
Journal:  CMAJ       Date:  1998       Impact factor: 8.262

6.  The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy.

Authors:  O Langer; L Brustman; A Anyaegbunam; R Mazze
Journal:  Am J Obstet Gynecol       Date:  1987-09       Impact factor: 8.661

7.  Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators.

Authors:  C D Naylor; M Sermer; E Chen; K Sykora
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

8.  Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity.

Authors:  M S Magee; C E Walden; T J Benedetti; R H Knopp
Journal:  JAMA       Date:  1993-02-03       Impact factor: 56.272

9.  Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population.

Authors:  S L Dooley; B E Metzger; N H Cho
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

10.  Prophylactic insulin treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery, and birth trauma.

Authors:  D R Coustan; J Imarah
Journal:  Am J Obstet Gynecol       Date:  1984-12-01       Impact factor: 8.661

View more
  5 in total

1.  Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome.

Authors:  Romana Dmitrovic; Heather I Katcher; Allen R Kunselman; Richard S Legro
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

2.  Evaluation of oral glucose tolerance test, β-cell function and adverse obstetric outcomes.

Authors:  Hongxiu Zhang; Dongmei Zhao; Jie Shen; Xiaoping Zhou; Wenwei Chen; Shiwen Jiang
Journal:  Biomed Rep       Date:  2013-07-16

Review 3.  Type 2 diabetes after gestational diabetes: The influence of changing diagnostic criteria.

Authors:  Eoin Noctor; Fidelma P Dunne
Journal:  World J Diabetes       Date:  2015-03-15

4.  Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values.

Authors:  Mary Helen Black; David A Sacks; Anny H Xiang; Jean M Lawrence
Journal:  Diabetes Care       Date:  2010-09-15       Impact factor: 19.112

5.  Prevalence of gestational diabetes mellitus and associated risk factors in Turkish women: the Trabzon GDM Study.

Authors:  Cihangir Erem; Ufuk B Kuzu; Orhan Deger; Gamze Can
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.